- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Adolescents (12-17 years)
- Outpatient clinic
- Primary care
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Ibuzatrelvir
Population: Adolescents (12-17 years)
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- Influenza-like illness/Acute respiratory infection
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Influenza-like illness/Acute respiratory infection
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Influenza virus
- Influenza-like illness/Acute respiratory infection
- Blood sample
- Nasopharyngeal swab
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Influenza-like illness/Acute respiratory infection
- Diagnostics
- Point of care tests
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Influenza virus
- Adenovirus
- Rhinovirus
- Enterovirus
- Human coronavirus NL63
- Streptococcus pyogenes
- Influenza-like illness/Acute respiratory infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Influenza-like illness/Acute respiratory infection
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Group A Streptococcus
- Influenza A virus
- Influenza B virus
- Influenza-like illness/Acute respiratory infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Enterovirus
- Bordetella pertussis
- Seasonal coronavirus
- Bordetella parapertussis
- Chlamydia pneumoniae
- Mycoplasma pneumoniae
- Influenza-like illness/Acute respiratory infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Influenza-like illness/Acute respiratory infection
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Primary care
- Influenza-like illness/Acute respiratory infection
- Pharmacological intervention
- Telehealth
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Influenza-like illness/Acute respiratory infection